Jasper Therapeutics Inc. (JSPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 115,812 | 129,400 | 38,250 | 50,950 | 60,814 |
| Receivables | 0 | N/A | 663 | N/A | N/A |
| TOTAL | $118,567 | $132,508 | $41,731 | $52,411 | $63,286 |
| Non-Current Assets | |||||
| PPE Net | 3,056 | 3,320 | 3,568 | 3,759 | 4,016 |
| Other Non-Current Assets | 2,547 | 2,929 | 3,062 | 2,940 | 3,064 |
| TOTAL | $5,603 | $6,249 | $6,630 | $6,699 | $7,080 |
| Total Assets | $124,170 | $138,757 | $48,361 | $59,110 | $70,366 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,581 | 3,846 | 1,768 | 3,117 | 2,997 |
| Accrued Expenses | 6,474 | 3,155 | 4,432 | 3,464 | 2,841 |
| TOTAL | $8,972 | $7,892 | $7,065 | $7,421 | $6,622 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 4,993 | 5,667 | 5,307 | 4,124 | 4,963 |
| TOTAL | $4,993 | $5,667 | $5,307 | $4,124 | $4,963 |
| Total Liabilities | $13,965 | $13,559 | $12,372 | $11,545 | $11,585 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,080 | 11,033 | 10,938 | 3,707 | 3,669 |
| Common Shares | 11 | 11 | N/A | 4 | 4 |
| Retained earnings | -135,475 | -119,395 | -105,135 | -91,924 | -80,061 |
| TOTAL | $110,205 | $125,198 | $35,989 | $47,565 | $58,781 |
| Total Liabilities And Equity | $124,170 | $138,757 | $48,361 | $59,110 | $70,366 |